Hematopoietic and immune development
Pronk Group Our ResearchToday, we cure about 85% of children with cancer. In some subgroups, such as acute lymphoblastic leukemia (ALL), cure rates exceed 90%. Treating pediatric cancer patients is characterized by balancing of anti-tumor actions with treatment related morbidity/mortality. Many patients suffer from treatment toxicities during or following completion of treatment, sometime with a l
https://www.stemcellcenter.lu.se/research-groups/pronk - 2026-07-15
